Clinical Trial Update: Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of mitomycin C and ifosfamide for metastatic pancreatic cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED